Syndromes of resistance to thyroid hormone: Molecular and pathogenic basis;SYNDROMES DE RESISTANCE AUX HORMONES THYROIDIENNES: BASES MOLECULAIRES ET PATHOGENIQUES

Medecine/Sciences

Volumn 13, Issue 12, 1997, Pages 1419-1427

  Vlaeminck Guillem, Virginie ^a   Wémeau, Jean Louis ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; THYROID HORMONE; THYROID HORMONE RECEPTOR;

AUTOSOMAL RECESSIVE INHERITANCE; CONTROLLED STUDY; DIMERIZATION; DNA BINDING; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HYPOPHYSIS; LIGAND BINDING; MOLECULAR BIOLOGY; PHENOTYPE; PROTEIN DOMAIN; REVIEW; THYROID HORMONE RESISTANCE; TRANSACTIVATION;

EID: 0030712914     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/573     Document Type: Review

References (39)

1. Refetoff S, De Wind LT, De Groot LJ. Familial syndrome combining deaf mutism, stippled epiphysis, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. J Clin Endocrinol Metab 1967; 27: 279-94.
2. Refetoff S, Weiss RE, Usala SJ. The syndromes of resistance to thyroid hormone. Endocrinol Rev 1993; 14: 348-99.
3. Mixson AJ, Parrilla R, Ranson SC, Wiggs EA, Mc Claskey JH, Hauser P, Weintraub BD. Correlations of language abnormalities with localization of mutations in the β thyroid hormone receptor in 13 kindreds with generalized resistance to thyroid hormone: identification of four new mutations. J Clin Endocrinol Metab 1992; 75: 1039-45.
4. Kaplan MM, Swartz SL, Larsen PR. Partial peripheral resistance to thyroid hormone. Am J Med 1981; 70: 1115-21.
5. Wrutniak C, Cabello G. La voie d'action mitochondriale directe de la triiodothyronine: mythe ou réalité ? Med Sci 1996; 12: 475-84.
6. Lee Y, Mahdavi V. The D domain of the thyroid hormone receptor α1 specifies positive and negative transcriptional regulation functions. J Biol Chem 1993; 268: 2021-8.
7. Horowitz ZD, Yang CR, Forman BM, Casanova J, Samuels HH. Characterization of the domain structure of chicken c-ErbA by deletion mutation: in vitro translation and cell transfection studies. Mol Endocrinol 1989; 3: 148-56.
8. Cavailles V. N-CoR et SMRT sont des co-répresseurs transcriptionnels des récepteurs des hormones thyroïdiennes et de Pacide rétinoïque. Med Sci 1996; 12: 234-5.
9. Barettino D, Vivanco-Ruiz MDM, Stunnenberg HG. Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J 1994; 13: 3039-49.
10. Cavailles V. A la recherche de modulateurs de l'activité transcriptionnelle des récepteurs nucléaires. Med Sci 1996; 12: 229-33.
11. Yen PM, Chin WW. Molecular mechanisms of dominant negative activity by nuclear hormone receptors. Mol Endocrinol 1994; 8: 1450-4.
12. Wurtz JM, Bourget W, Renaud JP, Vivat V, Chambon P, Moras D, Gronemeyer H. A canonical structure for the ligand-binding omain of nuclear receptors. Nature Struct Biol 1996; 3: 87-94.
13. Landet V, Delannoy S. Comment mettre en mule un récepteur nucléaire ? Apport des données structurales. Med Sci 1996; 12: 528-32.
14. Sakurai A, Takeda K, Ain K, Ceccarelli P, Nakai A, Seino S, Bell GI, Refetoff S, De Groot LJ. Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor β. Proc Natl Acad Sci USA 1989; 86: 8977-81.
15. Sakurai A, Nakai A, De Groot JL. Structural analysis of human thyroid hormone receptor gene. Mol Cell Endocrinol 1990; 71: 83-91.
16. Takeda K, Sakurai A, De Groot LJ, Refetoff S. Recessive inheritance of thyroid hormone resistance caused by complete deletion of the protein-coding region of the thyroid hormone receptor β gene. J Clin Endocrinol Metab 1992; 74: 49-55.
17. Collingwood TN, Adams M, Tone Y, Chatterjee VKK. Spectrum of transcriptional dimerization, and dominant negative properties of twenty different mutant thyroid hormone β-receptors in thyroid hormone resistance syndrome. Mol Endocrinol 1994; 8: 1262-77.
18. Piedrafita FJ, Ortiz MA, Pfahl M. Thyroid hormone receptor-β mutants associated with generalized resistance to thyroid hormone show defects in their ligand-sensitive repression function. Mol Endocrinol 1995; 9: 1533-48.
19. Usala SJ, Bale AE, Gesundheit N, Weinberger C, Lash RW, Wondisford FE, McBride OW, Weintraub BD. Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erbAβ gene. Mol Endocrinol 1988; 2: 1217-20.
20. Vlaeminck V, Margotat A, Torresani J, D'Herbomez M, Decoulx M, Wémeau JL. Familial resistance to thyroid hormone (RTH) without triiodothyronine-receptor β1 (TRβ1) anomaly. Pathogenic hypothesis. J Endocrinol Invest 1997; 20 (suppl 5): 70 (abstract).
21. Zavacki AM, Harney JW, Brent GA, Larsen PR. Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific. Mol Endocrinol 1993; 7: 1319-30.
22. Wrutniak C, Cassar-Malek I, Marechal S, Rascle A, Heusser S, Keller JM, Fléchon J, Dauça M, Samarut J, Ghvsdael J, Cabello G. A 43-kDa protein related to c-erbα1 is located in the mitochondrial matrix of rat liver. J Biol Chem 1995; 270: 16347-54.
23. Takeda K, Weiss RE, Refetoff S. Rapid localization of mutations in the thyroid hormone receptor β gene by denaturing gradient gel electrophoresis in 18 families with thyroid hormone resistance. J Clin Endocrinol Metab 1992; 74: 712-9.
24. Weiss RE, Hayashi Y, Nagaya T, Petty KJ, Murata Y, Seo H, Refetoff S. Familial resistance to thyroid hormone (RHT) not linked to defects in the thyroid hormone receptors (TR) α or β genes. Thyroid 1995; 5 (suppl 1): S-68.
25. Usala SJ, Menke JB, Watson TL, Weintraub BD, Berard J, Bradley WEC, Ono S, Mueller OT, Bereu BV. A homozyeous deletion in the c-ErbA β thyroid hormone receptor gene in a patient with generalized thyroid hormone resistance: isolation and characterization of the mutant receptor. Mol Endocrinol 1991; 5: 327-35.
26. Chatterjee VKK, Nagaya T, Madison LD, Datta S, Rentoumis A, Jameson JL. Thyroid hormone resistance syndrome. J Clin Invest 1991; 87: 1977-84.
27. Nagaya T, Madison LD, Jameson JL. Thyroid receptor mutants that cause resistance to thyroid hormone. J Biol Chem 1992; 267: 13014-9.
28. Damm K, Thompson CC, Evans RM. Protein encoded by v-ErbA functions as a thyroid hormone receptor antagonist. Nature 1989; 339: 593-7.
29. Selmi S, Samuels HH. Thyroid hormone receptor and v-ErhA. Single amino acid difference in the C-terminal region influences dominant activity and receptor dimers formation. J Bid Chem 1991; 266: 11589-93.
30. 2) is due to competition for binding sites on target genes. J Biol Chem 1993; 268: 20904-10.
31. Nagaya T, Jameson JL. Thyroid hormone receptor dimerization is required for dominant negative inhibition by mutations that cause thyroid hormone resistance. J Biol Chem 1993; 268: 15766-71.
32. Saitou M, Nurumiya S, Kakisuka A. Alteration of a single amino acid residue in retinoic acid receptor causes dominant negative phenotype. J Biol Chem 1994; 269: 19101-7.
33. Kitajima A, Nagaya T, Jameson JL. Dominant negative and DNA-binding properties of mutant thyroid hormone receptors that are defective in homodimerization but not heterodimerization. Thyroid 1995; 5: 343-53.
34. Barettino D, Bugge TH, Bartunek P, Vivanco-Ruiz MM, Sonntag-Buck V, Beug H, Zenke M, Stunneberg HG. Unliganded T3R, but not its oncogenic variant, v-ErbA, suppresses RAR-denendent transactivation by titrating out RXR. EMBO J 1993; 12: 1443-54.
35. Behr M, Loos U. A point mutation (Ala 229 to Thr) in the hinge domain of the c-ErbA β thyroid hormone receptor gene in a family with generalized thyroid hormone resistance. Mol Endocrinol 1992; 6: 1119-26.
36. Pagliara AS, Caplan RH, Gundersen CB, Wickus GG, Elston ACV. Peripheral resistance to thyroid hormone in a family: heterogeneity of clinical presentation. J Pediatr 1983; 103: 228-32.
37. Beck-Peccoz P, Chatterjee VKK. The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 1994; 4: 225-34.
38. Flynn TR, Hollenberg AN, Cohen O, Menke JB, Usala SJ, Tollin S, Hegarti MK, Wondisford FE. A novel C-terminal domain in the thyroid hormone receptor selectively mediates thyroid hormone inhibition. J Biol Chem 1994; 269: 32713-6.
39. Nagaya T, Eberhardt NL, Jameson JL. Thyroid hormone resistance syndrome: correlation of dominant negative activity and location of mutations. J Clin Endocrinol Metab 1993; 77: 982-90.